- $1.94tn
- $1.85tn
- $307.39bn
- 99
- 22
- 80
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 161,857 | 182,527 | 257,637 | 282,836 | 307,394 |
Cost of Revenue | |||||
Gross Profit | 89,961 | 97,795 | 146,698 | 156,633 | 175,022 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 127,626 | 141,303 | 178,923 | 207,994 | 223,101 |
Operating Profit | 34,231 | 41,224 | 78,714 | 74,842 | 84,293 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 39,625 | 48,082 | 90,734 | 71,328 | 85,717 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34,343 | 40,269 | 76,033 | 61,572 | 75,895 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 34,343 | 40,269 | 76,033 | 59,972 | 73,795 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 34,343 | 40,269 | 76,033 | 59,972 | 73,795 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.56 | 2.93 | 5.61 | 4.68 | 6.24 |